CannLabs (OTCMKTS:CANL – Get Rating) and Personalis (NASDAQ:PSNL – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends. Profitability This table compares CannLabs and Personalis’ net margins, return on […]
CannLabs (OTCMKTS:CANL – Get Rating) and Personalis (NASDAQ:PSNL – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings. Insider and Institutional Ownership 60.8% of Personalis shares are owned by […]
Nebula Genomics Strengthens Advisory Board with Appointment of Russ Altman, M.D., Ph.D. - read this article along with other careers information, tips and advice on BioSpace
ProPhase Labs (PRPH) Appoints Russ Altman to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
GARDEN CITY, NY, Oct. 17, 2022 ProPhase Labs, Inc. , a growth-oriented and diversified diagnostics, genomics and biotech company, today announced that its wholly owned subsidiary, Nebula. | October 17, 2022